Breast cancer in mothers prescribed diethylstilbestrol in pregnancy, 1993 further follow-up

Further assessment of the long-term risk of breast cancer associated with DES during pregnancy

image of woman-thinking
Contrary to prior indications, the modest but statistically significant increased risk of breast cancer does not appear to increase greatly over time. Image via Hernán Piñera.

1993 Study Abstract

OBJECTIVE:
Further assessment of the long-term risk of breast cancer associated with diethylstilbestrol (DES) during pregnancy.

DESIGN:
Follow-up continuation through June 1, 1989, of a historical cohort of DES-exposed and unexposed mothers ascertained by review of obstetric records.

PARTICIPANTS:
Totals of 3029 each of DES-exposed and unexposed mothers who had delivered live babies at four centers in the United States during 1940 through 1960. Questionnaires were returned for 92.6% of the DES-exposed and 88.8% of the unexposed women.

MAIN OUTCOME MEASURES:
Breast cancer incidence and mortality assessed from returned questionnaires and review of medical records and death certificates.

MAIN RESULTS:
The relative rate of breast cancer associated with DES exposure, after adjustment for demographic and reproductive variables, was 1.35 (95% confidence interval, 1.05 to 1.74). For 30 years or more following exposure, the relative rate was not appreciably higher (relative rate, 1.33; 95% confidence interval, 0.95 to 1.87) than that in earlier periods. Surveillance and increased detection seemed unlikely explanations for the increased risk, since DES-exposed women had excesses of both large and small breast cancers and the two cohorts reported similar breast cancer detection practices. A history of miscarriage before first term delivery was not associated with breast cancer occurrence.

CONCLUSION:
Exposure to DES during pregnancy is associated with a modest but statistically significant increased risk of breast cancer. Contrary to prior indications, the risk does not appear to increase greatly over time. The findings are sufficient to exclude the possibility of a doubling of risk for the period of 30 or more years following exposure.

Sources
  • Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up., Colton T1, Greenberg ER, Noller K, Resseguie L, Van Bennekom C, Heeren T, Zhang Y. NCBI PMID: 8468763. 1993 Apr 28;269(16):2096-100.
  • Full text, JAMA, 1993;269(16):2096-2100. doi:10.1001/jama.1993.03500160066033, April 28, 1993.
More DES DiEthylStilbestrol Resources

Author: DES Daughter

Activist, blogger and social media addict committed to shedding light on a global health scandal and dedicated to raise DES awareness.

2 thoughts on “Breast cancer in mothers prescribed diethylstilbestrol in pregnancy, 1993 further follow-up”

Have your say! Share your views

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.